NCT05457855View on ClinicalTrials.gov

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone

CompletedOBSERVATIONAL
Enrollment

51,533

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

July 7, 2023

Study Completion Date

December 31, 2023

Conditions
Asthma
Interventions
DRUG

Montelukast

Montelukast claim is used as the exposure group.

DRUG

Fluticasone

Fluticasone claim is used as the reference group.

Trial Locations (1)

02120

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

Rutgers University

OTHER

collaborator

Johns Hopkins University

OTHER

lead

Brigham and Women's Hospital

OTHER